financetom
Business
financetom
/
Business
/
Walmart Launches AI-Powered Tool on Commerce Platform, Launches Test With Weaving Start-Up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walmart Launches AI-Powered Tool on Commerce Platform, Launches Test With Weaving Start-Up
Mar 14, 2024 7:34 AM

09:58 AM EDT, 03/14/2024 (MT Newswires) -- Walmart ( WMT ) said Thursday that it has made an AI-powered logistics management tool, Route Optimization, available to businesses as a software as a service through Walmart Commerce Technologies.

The software uses artificial intelligence tools to plan driving routes and pack trucks, the company said.

Separately, Walmart ( WMT ) said it is starting a pilot project with Unspun, a fashion company using 3D weaving technology to automate textile manufacturing. The new technology aims to reduce waste and increase efficiency in the garment industry.

The pilot project will seek to use Unspun's machines to make workwear-style pants under a Walmart brand.

Financial terms of the collaboration were not disclosed.

Price: 61.11, Change: +0.04, Percent Change: +0.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves BeiGene's esophageal cancer therapy
US FDA approves BeiGene's esophageal cancer therapy
Mar 14, 2024
March 14 (Reuters) - The U.S. Food and Drug Administration has approved BeiGene's ( BGNE ) drug to treat a type of esophageal cancer in patients who have previously received chemotherapy. ...
Cybin Reaches Alignment With FDA on Late-Stage Design For Major Depressive Disorder Trial
Cybin Reaches Alignment With FDA on Late-Stage Design For Major Depressive Disorder Trial
Mar 14, 2024
02:18 PM EDT, 03/14/2024 (MT Newswires) -- Cybin ( CYBN ) said Thursday it has received minutes from a End-of-Phase-2 meeting with the US Food and Drug Administration and reached alignment on its Phase 3 program design for CYB003 for the adjunctive treatment of major depressive disorder. Cybin ( CYBN ) said it aims to start enrollment in mid-2024, with...
Platinum Equity explores $2 billion-plus Club Car sale, sources say
Platinum Equity explores $2 billion-plus Club Car sale, sources say
Mar 14, 2024
March 14 (Reuters) - Private equity firm Platinum Equity has hired advisers to explore a sale of Club Car that could value the golf cart maker at more than $2 billion, including debt, people familiar with the matter said. Platinum Equity is in the early stages of working with investment bank Goldman Sachs ( GS ) on the sale, which...
Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline
Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline
Mar 14, 2024
02:11 PM EDT, 03/14/2024 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) reported Q4 net loss Thursday of $0.58 per diluted share, narrowing from the loss of $0.63 a year earlier. Analysts polled by Capital IQ expected a loss of $0.39. Cash and cash equivalents in the quarter ended Dec. 31 rose to $128.1 million from $54.9 million a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved